A clinical trial to study the effect of a polyherbomineral drug, Eladi Churna in patients with diabetic kidney disease.

Clinical study to evaluate the nephroprotective effect of Eladi Churna in Diabetic Kidney Disease.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054530

Enrollment

Registered

2023-06-28

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients coming under diagnostic criteria of DKD 2.Patients with and without Dialysis 3.Patients between 18 years to 70 years of age irrespective of sex

Exclusion criteria

Exclusion criteria: 1.Patients less than 18 years and more than 70 years 2.Patients suffering from CAD 3.CLD 4.MALIGNANCY 5.TB 6.ASCITES 7.STD 8.Pregnant,Expecting and lactating mothers 9.Other complications of Diabetes Mellitus 10.Patient with recurrent UTI 11.marked HTN as it fallaciously rise microalbuminuria

Design outcomes

Primary

Measure	Time frame
1. To increase Urinary Output/24hr 2. To decrease Nausea, Vomiting, Pedal Oedema, Fatigue, Loss of Appetite, Retro orbital oedema, Muscle crampsTimepoint: Baseline , 15 days , 30 days, 45 days, 60 days, 75 days, 90 days	—

Secondary

Measure	Time frame
To bring Urine albumin, Sr Creatinine, eGFR, FBS , PPBS, Hba1C, BUN to normal rangeTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Ranjan Kalita

Government Ayurvedic College and Hospital, Guwahati , Assam

jupitoradutta95@gmail.com9954584743

Outcome results